Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Predictive prioritization of functional enhancers in human pancreas cells [ATAC-Seq]

ABSTRACT: We mapped accessible chromatin regions genome-wide in purified human pancreas cell types

ORGANISM(S): Homo sapiens

PROVIDER: GSE245479 | GEO | 2024/10/15

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Predictive prioritization of functional enhancers in human pancreas cells [HiChIP]

Project description:We mapped enhancer-promoter interactions genome-wide in purified human pancreas cell types

2024-10-15 | GSE245482 | GEO

Predictive prioritization of functional enhancers in human pancreas cells [ATAC-Seq]

Project description:Predictive prioritization of functional enhancers in human pancreas cells [ATAC-Seq]

| PRJNA1028579 | ENA

Predictive prioritization of functional enhancers in human pancreas cells

Project description:Predictive prioritization of functional enhancers in human pancreas cells

| PRJNA1028575 | ENA

Predictive prioritization of functional enhancers in human pancreas cells [HiChIP]

Project description:Predictive prioritization of functional enhancers in human pancreas cells [HiChIP]

| PRJNA1028582 | ENA

Predictive prioritization of functional enhancers in human pancreas cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-10-15 | GSE245484 | GEO

Heparin-binding proteome in normal pancreas and murine experimental pancreatitis_C4PR_LIV

Project description:Acute pancreatitis (AP) is acute inflammation of the pancreas, mainly caused by gallstones and alcohol, driven by changes in communication between cells. Heparin-binding proteins (HBPs) play a central role in cell communication. Therefore, we used heparin affinity proteomics to identify extracellular HBPs in pancreas and plasma of normal mice and in a caerulein mouse model of AP. Many new extracellular HBPs (360) were discovered in the pancreas, taking the total number of HBPs known to 786. Extracellular pancreas HBPs form highly interconnected protein-protein interaction networks in both normal pancreas (NP) and AP. Thus, HBPs represent an important set of extracellular proteins with significant regulatory potential in the pancreas. HBPs in NP are associated with biological functions such as molecular transport and cellular movement that underlie pancreatic homeostasis. However, in AP HBPs are associated with additional processes such as acute phase response signalling, complement activation and mitochondrial dysfunction. Plasma HBPs in AP included known AP biomarkers such as serum amyloid A, as well as emerging targets such as histone H2A. Pancreas HBPs are extracellular and so easily accessible and are potential drug targets in AP, whereas plasma HBPs represent potential biomarkers for AP.

2018-12-17 | PXD012039 | Pride

Genomic Landscape and Therapeutic Targets of Adenosquamous Carcinoma of the Pancreas [ATAC-seq]

Project description:We applied DNA content flow cytometry to a series of adenosquamous cancer of the pancreas (ASCP) tumor samples and patient derived xenografts (PDXs). We interrogated purified sorted tumor fractions from each sample with whole genome copy number variant (CNV) and whole exome sequencing (WES) analyses. These identified a variety of somatic genomic lesions targeting chromatin regulators in ASCP genomes that were superimposed on well characterized genomic lesions including mutations in KRAS and TP53, homozygous deletion of CDKN2A, and amplification of c-MYC, that are common in PDACs. Furthermore, a comparison of ATAC-seq profiles of ASCP and pancreatic ductal adenocarcinoma (PDAC) genomes using flow sorted PDX models distinguished genes with accessible chromatin in ASCP genomes including the lysine methyltransferase SMYD2, the pancreatic cancer stem cell driver RORγ, and a FGFR1-ERLIN2 fusion associated with focal CNVs in both genes. Organoids derived from these models were used to screen compounds of interest. Notably a FGFR inhibitor had significant activity against the FGFR1-ERLIN2 fusion positive PDX.

2020-01-14 | GSE143563 | GEO

ATAC-seq from pancreas (ENCSR530XBF)

Project description:ATAC-seq on human pancreas For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2021-03-30 | GSE170507 | GEO

ATAC-seq from pancreas (ENCSR251POP)

2021-03-29 | GSE170023 | GEO

ATAC-seq from pancreas (ENCSR808ZMK)

2021-03-29 | GSE170216 | GEO